Product
Epoprostenol Sodium & Milrinone
1 clinical trial
2 indications
Indication
Right Heart FailureIndication
Right Ventricular DysfunctionClinical trial
Inhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass Separation: A Randomized, Double-blind, Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2025-06-01